Helen Reeves (BMedSci, BM, BS, PhD, FRCP) graduated from Nottingham Medical school in 1990, moving shortly afterwards to Newcastle-upon-Tyne under the mentorship of Professor Oliver James.
Between 1993 and 1997, funded by a Wellcome Trust Clinical Training Fellowship, she pursued studies for her PhD entitled ‘Cell Signalling Pathways involved in the Activation and Proliferation of hepatic stellate cells’. In parallel she worked as a research registrar on the Freeman Hospital Liver Transplant unit. After completing her clinical training in gastroenterology between 1997 and 2000, funded by the Peel Medical Research Trust and subsequently an AASLD scholarship, she worked for 3 years as a post-doctoral scientist with Professor Scott Friedman at Mount Sinai Medical School in New York. During this time, her focus broadened from fibrogenesis research to include the molecular pathogenesis of cancers.
Dr. Helen Louise Reeves
Northern Institute for Cancer Research
Paul 'O Gorman Building
The Medical School
NE2 4HH, United Kingdom
Tel: Work: (+44) 191 246 4423
Tel: Clinical Secretary: (+44) 191 2137210
She returned to the UK in 2003, as GSK funded Senior Clinician Scientist at Newcastle University Medical School and from 2004 she has worked as Senior Lecturer and Honorary Consultant Gastroenterologist. Within the Newcastle-upon-Tyne NHS Foundation Trust HPB multidisciplinary team, she is the clinical lead for the care of patients with hepatocellular cancer in Northern England. She has created the Newcastle University Gastroenterology Tissue bank to support translational research for the benefit of patients with chronic disease and cancer. Her own research is within the clinical and translational laboratories of the Northern Institute for Cancer Research. She works very closely with the Newcastle Liver group and is part of the European Funded ‘FLIP – Fatty Liver Inhibition of Progression’ team. She is also a part of the Newcastle Cancer Research UK funded Drug Discovery group, with two candidate therapeutic targets in development for the treatment of patients with hepatocellular cancer. She has published original papers in a number of scientific jounals, including Science, Gastroenterology, Hepatology and Journal of Hepatology.
She enjoys teaching and mentoring young researchers and as a committee member for the British Association for Cancer Research, she sits on the Training and Fellowships sub committee. Her research team includes one post doctoral scientist, one technician, 3 PhD students, one clinical MD student, an MRes student and an MSci student.